You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 July 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) announced on Tuesday that it has agreed an exclusive worldwide licence with China's Dizal Pharmaceutical Co., Ltd (SSE: 688192) for Zegfrovy (sunvozertinib)...
14 July 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) on Tuesday announced an agreement to sell ridinilazole, an investigational Phase III precision antibiotic, to Toronto-based Biossil Inc, an AI-native biopharma co...
14 July 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Tuesday that the European Commission has approved an updated label for Erbitux (cetuximab), allowing its use in combination w...
13 July 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has received marketing authorisation in Sweden for Tofacitinib Newbury 5 mg and 10 mg film-coated tablets, marking the first approval in...
13 July 2026 - Evaxion A/S (NASDAQ: EVAX), a Denmark-based clinical-stage TechBio company developing novel vaccines with its AI-Immunology platform, on Sunday presented new data further supporting the multi-component concept of its cytomegalovirus (C...
13 July 2026 - US-based clinical-stage biotechnology company HDT Bio Corp announced on Sunday the establishment of HDT Bio Canada Inc, its Canadian subsidiary, formed to advance its cancer immunotherapy programs through Canadian clinical development,...
13 July 2026 - Clinical-stage biotechnology company Insilico Medicine (HKEX:3696) announced on Sunday that it has agreed an additional AI-empowered drug discovery collaboration with China Medical System Holdings Limited (CMS) (HKEX:867) (SGX:8A8) tar...